KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Inventory Average (2016 - 2022)

TherapeuticsMD's Inventory Average history spans 10 years, with the latest figure at $6.4 million for Q3 2022.

  • For Q3 2022, Inventory Average fell 13.96% year-over-year to $6.4 million; the TTM value through Sep 2022 reached $6.4 million, down 13.96%, while the annual FY2021 figure was $7.8 million, 21.35% down from the prior year.
  • Inventory Average reached $6.4 million in Q3 2022 per TXMD's latest filing, down from $7.6 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $13.2 million in Q1 2020 to a low of $1.6 million in Q1 2018.
  • Average Inventory Average over 5 years is $7.1 million, with a median of $7.5 million recorded in 2021.
  • Peak YoY movement for Inventory Average: surged 323.3% in 2019, then plummeted 42.05% in 2021.
  • A 5-year view of Inventory Average shows it stood at $2.8 million in 2018, then surged by 296.63% to $11.2 million in 2019, then decreased by 19.95% to $9.0 million in 2020, then dropped by 16.41% to $7.5 million in 2021, then dropped by 14.24% to $6.4 million in 2022.
  • Per Business Quant, the three most recent readings for TXMD's Inventory Average are $6.4 million (Q3 2022), $7.6 million (Q2 2022), and $8.3 million (Q1 2022).